ArticleBMC pulmonary medicine2025
The impact of the triglyceride-glucose index on the risk of respiratory failure in patients with COPD: a study from the MIMIC database and Chinese cohorts.
Article in BMC pulmonary medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Association of triglyceride-glucose index and triglyceride-glucose body mass index with risk and prognosis of chronic obstructive pulmonary disease: a systematic review and meta-analysis.Journal of thoracic disease · 2026Article
- Biomarkers for Chronic Kidney Disease: An Updated Review of Innovative Detection Approaches.Current aging science · 2026Review
- Association of triglyceride-glucose related indices with all-cause and cardiovascular mortality in patients with chronic obstructive pulmonary disease: a large prospective cohort study.Nutrition journal · 2025Article
- Inflammation and Albumin-Based Biomarkers Are Not Independently Associated with Mortality in Critically Ill COPD Patients: A Retrospective Study.Life (Basel, Switzerland) · 2025Article
- Correlation of C-reactive protein/albumin ratios and electrolytes with APACHE II score and prognosis in patients with chronic obstructive pulmonary disease.American journal of translational research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundThe Triglyceride-Glucose (TyG) index, a reliable marker for insulin resistance, is now employed to assess the onset and prognosis of various conditions like acute coronary syndrome, chronic kidney disease, and ischemic stroke. However, whether the TyG index can be used to assess respiratory failure (RF) risk among Chronic obstructive pulmonary disease (COPD) patients remains uncertain. The present study aims to delve into the link between the TyG index and the risk of RF in COPD patients.
methodsIndividuals with COPD were retrospectively acquired from the MIMIC-IV 2.2 (The Medical Information Mart for Intensive Care IV, version 2.2) database. The association between the TyG index and the probability of RF among COPD patients was evaluated using Cox proportional hazards models and restricted cubic spline (RCS) curves. Cumulative incidence curves were generated to appraise the RF risk across the quartile groups. Finally, 1188 patients were recruited from the First Hospital of Jiaxing City to externally validate the Cox modeling results for the primary outcome.
resultsThis study incorporated a total of 1,232 participants from MIMIC database. Among these individuals, 134 cases (10.9%) experienced RF. According to Cox regression analysis, a one-unit increment in the TyG index was linked to a 1.821-fold elevated risk of RF in the COPD population (HR, 1.821[95% CI 1.349-2.459], P < 0.001). High TyG index levels were significantly linked to a higher RF risk (HR, 3.510 [95% CI 1.885-6.535], P < 0.001). RCS curve analysis also signaled a linear correlation between the TyG index and RF risk (P-Nonlinear = 0.074).
conclusionThere exists a certain correlation between high-level TyG index and the risk of RF occurrence in COPD patients, indicating promising prospects for utilizing the TyG index to assess the severity of COPD patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.